» Articles » PMID: 30421454

Attributable Risk of Alzheimer's Dementia Attributed to Age-related Neuropathologies

Overview
Journal Ann Neurol
Specialty Neurology
Date 2018 Nov 14
PMID 30421454
Citations 128
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The degree to which Alzheimer's versus other neuropathologies contribute to the risk of Alzheimer's dementia is unknown. We examined the risk of Alzheimer's dementia attributable to pathologic AD and 8 other neuropathologies.

Methods: Participants (n = 1,161) came from 2 clinical-pathological studies of aging. Multivariable logistic regression models examined associations of 8 neuropathological indices with Alzheimer's dementia and quantified the percentage of cases attributable to each. Furthermore, because some dementia cases are not driven by common neuropathologies, we re-estimated the attributable risks after empirically adjusting for such cases.

Results: Of 1,161 persons, 512 (44.1%) had Alzheimer's dementia at time of death. With the exception of microinfarcts, all neuropathological indices were independently associated with greater odds of Alzheimer's dementia. Two hundred ten (41.0%) Alzheimer's dementia cases were attributable to pathological AD. Separately, 8.9% were attributable to macroscopic infarcts, 10.8% to Lewy bodies, 5.2% to hippocampal sclerosis, 11.7% to transactive response DNA-binding protein 43, 8.1% to cerebral amyloid angiopathy, 6.0% to atherosclerosis, and 5.2% to arteriolosclerosis. A total of 83.3% of cases were attributable to all 8 indices combined. However, after further adjustment for cases driven by other factors, a total of 67.5% of cases were attributable to all 8 neuropathologic indices combined.

Interpretation: Pathological AD accounts for a considerable percentage of Alzheimer's dementia cases, but multiple other neuropathologies also contribute. In total, just over two-thirds of Alzheimer's dementia cases are attributable to common age-related neuropathologies, suggesting that other disease and resilience factors are important. ANN NEUROL 2019;85:114-124.

Citing Articles

Biological signatures in the Alzheimer's continuum discriminate between diagnosis-related and -unrelated associations to ATN categories.

Alanko V, Mravinacova S, Hall A, Hagman G, Mohanty R, Westman E Brain Commun. 2025; 7(2):fcaf078.

PMID: 40046342 PMC: 11881062. DOI: 10.1093/braincomms/fcaf078.


Structural variants linked to Alzheimer's disease and other common age-related clinical and neuropathologic traits.

Vialle R, de Paiva Lopes K, Li Y, Ng B, Schneider J, Buchman A Genome Med. 2025; 17(1):20.

PMID: 40038788 PMC: 11881306. DOI: 10.1186/s13073-025-01444-6.


Amyloid is associated with accelerated atrophy in cognitively unimpaired individuals.

Stephenson H, Betthauser T, Langhough R, Jonaitis E, Du L, Van Hulle C Alzheimers Dement (Amst). 2025; 17(1):e70089.

PMID: 39996035 PMC: 11848556. DOI: 10.1002/dad2.70089.


Unraveling the link between frailty and Alzheimer's disease biomarkers in patients with mild cognitive impairment.

Buscarnera S, Canevelli M, Bruno G, Garibotto V, Frisoni G, Ribaldi F Geroscience. 2025; .

PMID: 39930290 DOI: 10.1007/s11357-025-01547-3.


Molecular hallmarks of excitatory and inhibitory neuronal resilience and resistance to Alzheimer's disease.

Castanho I, Yeganeh P, Boix C, Morgan S, Mathys H, Prokopenko D bioRxiv. 2025; .

PMID: 39868232 PMC: 11761133. DOI: 10.1101/2025.01.13.632801.


References
1.
Brookmeyer R, Kawas C, Abdallah N, Paganini-Hill A, Kim R, Corrada M . Impact of interventions to reduce Alzheimer's disease pathology on the prevalence of dementia in the oldest-old. Alzheimers Dement. 2016; 12(3):225-32. PMC: 4808364. DOI: 10.1016/j.jalz.2016.01.004. View

2.
James B, Wilson R, Boyle P, Trojanowski J, Bennett D, Schneider J . TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia. Brain. 2016; 139(11):2983-2993. PMC: 5091047. DOI: 10.1093/brain/aww224. View

3.
Wilson R, Yu L, Trojanowski J, Chen E, Boyle P, Bennett D . TDP-43 pathology, cognitive decline, and dementia in old age. JAMA Neurol. 2013; 70(11):1418-24. PMC: 3830649. DOI: 10.1001/jamaneurol.2013.3961. View

4.
White L, Small B, Petrovitch H, Ross G, Masaki K, Abbott R . Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study. J Geriatr Psychiatry Neurol. 2005; 18(4):224-7. DOI: 10.1177/0891988705281872. View

5.
Bennett D . Mixed pathologies and neural reserve: Implications of complexity for Alzheimer disease drug discovery. PLoS Med. 2017; 14(3):e1002256. PMC: 5349649. DOI: 10.1371/journal.pmed.1002256. View